News

AgroSpheres Named on Both the World’s Top GreenTech Companies 2025 and America’s Top GreenTech Companies 2025 Lists by TIME Magazine

AgroSpheres has been named on both the World’s Top GreenTech Companies 2025 and America’s Top GreenTech Companies 2025 lists. These prestigious awards are presented by TIME and Statista Inc., the leading statistics portal and industry ranking provider. The award lists were announced on March 25th, 2025, and can be viewed on TIME’s website.

Statista ranked the winners based on three evaluation criteria:

  • Positive environmental impact: The scoring is based on impact data such as the quality and impact of their product/service portfolio, as well as the expertise of their leadership team provided by HolonIQ
  • Financial strength: The scoring is based on the analysis of financial data points e.g., revenue, employee or funding information
  • Innovation drive: The scoring is based on the Patent Asset Index featured in LexisNexis® Intellectual Property Solutions

“Being recognized by TIME as one of the top GreenTech companies in both the U.S. and globally is a testament to the power of science-driven innovation in reshaping agriculture and our strong business fundamentals,” said Payam Pourtaheri, Co-Founder and CEO of AgroSpheres. “We have built a solid financial foundation to support the rapid commercialization of our bio-based solutions, ensuring long-term impact for growers and the environment. This recognition reinforces our mission to lead the way in the bio-based revolution.”

“Innovation drive and impact go hand in hand,” added Ameer Shakeel, AgroSpheres’ Co-Founder and CTO. “We have built an end-to-end technology platform, rooted in cutting-edge science, novel active ingredients and a strong intellectual property portfolio. Our advancements in encapsulation and delivery technologies are paving the way for greener, more effective crop protection solutions across the industry. As we scale our operations to commercialization, this honor from TIME highlights the growing momentum behind sustainable agriculture worldwide.”

In support of the research, Statista gathered data from company applications, annual reports, media monitoring, and other public sources. Additionally, Statista worked with specialized data partners HolonIQ and LexisNexis® Intellectual Property Solutions to further strengthen the data quality.

Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys.

Read more here.

Recent News

04/15/2026

Gov. Spanberger and Homegrown Innovator Agrospheres Celebrate Launch of Virginia’s new Biomanufacturing Facility

AgroSpheres, Inc., a Charlottesville-based agricultural biotechnology company, officially opened its first commercial biomanufacturing facility, representing a milestone for AgroSpheres and the biotech ecosystem. Speakers at the ribbon-cutting ceremony included: Virginia Governor Abigail Spanberger, AgroSpheres co-founders CEO Payam Pourtaheri and CTO Ameer Shakeel, Albemarle County Chair of the Board of Supervisors Ned Gallaway, President of the

04/08/2026

Likarda and The Tiny Cargo Company Announce Strategic Partnership to Advance Next-Generation Delivery of Biologics, Peptides and Small Molecules

Likarda, Inc., a leader in hydrogel-based drug delivery technologies, today announced a strategic partnership with Tiny Cargo, an innovator in extracellular vesicle (EV) delivery systems. The collaboration will focus on advancing the delivery of biologics and small molecules by integrating Likarda’s Core-Shell Spherification® (CSS®) platform with Tiny Cargo’s vesicle-based technologies. The partnership is designed to

04/08/2026

ReAlta Life Sciences Closes Oversubscribed $40 Million Financing Round to Advance Pegtarazimod Phase 2 Program in Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the closing of an oversubscribed $40 million financing. This brings the total capital raised to date to more than $150 million.